Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Search results

Found 12404 matches for

Evotec SE, a drug discovery and development solutions company, today announced a partnership agreement with the University of Oxford regarding access to biospecimens from the biobank Quality in Organ Donation (QUOD), an initiative of the Nuffield Department of Surgical Sciences (NDS) at the University of Oxford in close collaboration with the National Health Service Blood and Transplant (NHSBT) organisation in the UK.

Quality in Organ Donation (QUOD) logo

Sign up to our newsletter

Sign up to our newsletter to receive the latest news, insights and events directly to your inbox.

Participant Interest Form

Online induction completion

Join our research community

Join the Restore-B research community for breast reconstruction

SITU Expression of Interest Form

  • QUOD provides access to biospecimens from healthy organ donors and compromised patients with liver disease  
  • Adding data from several thousands of individual specimens significantly expands Evotec's existing patient database and will allow a unique understanding of disease mechanisms across indications

 

Categories

Similar stories